A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
NCT05225974
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Therapeutic Equivalency
Interventions
DRUG:
Liraglutide injection
DRUG:
Liraglutide injection(Victoza®)
Sponsor
The Affiliated Hospital of Qingdao University